This is a brief taken from the publisher’s feed. It is not a Gulf Latin report.
Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
The full text stays with the original publisher. We carry the headline, a short excerpt, and a link.

